Dr. Luskin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
450 Brookline Ave
Boston, MA 02215
Education & Training
- Brigham and Women's HospitalChief Residency, Internal Medicine, 2015 - 2016
- University of PennsylvaniaMSCE, Epidemiology, 2013 - 2015
- University of Pennsylvania Health SystemFellowship, Hematology and Medical Oncology, 2012 - 2015
- Brigham and Women's HospitalResidency, Internal Medicine, 2009 - 2012
- Perelman School of Medicine at the University of PennsylvaniaClass of 2009
Certifications & Licensure
- RI State Medical License 2022 - 2026
- MA State Medical License 2009 - 2025
- ME State Medical License 2022 - 2025
- NH State Medical License 2023 - 2025
- CT State Medical License 2022 - 2024
- PA State Medical License 2012 - 2016
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- ABL001 + Dasatinib + Prednisone + Blinatumomab in BCR-ABL+ B-ALL or CML Start of enrollment: 2018 Jul 24
- Ruxolitinib in Thrombocythemia and Polycythemia Vera Start of enrollment: 2022 Mar 21
Roles: Contact, Principal Investigator
- Venetoclax Plus Inotuzumab for B-ALL Start of enrollment: 2021 Sep 24
Roles: Principal Investigator, Contact
- Join now to see all
Publications & Presentations
PubMed
- 198 citationsIncreasing use of allogeneic hematopoietic cell transplantation in patients aged 70 years and older in the United StatesLori Muffly, Marcelo C. Pasquini, Michael Martens, Ruta Brazauskas, Xiaochun Zhu
Blood. 2017-08-31 - 10 citationsEffect of BMI on toxicities and survival among adolescents and young adults treated on DFCI Consortium ALL trials.Shai Shimony, Yael Flamand, Yannis K Valtis, Andrew E Place, Lewis B Silverman
Blood Advances. 2023-09-26 - 23 citationsAlisertib Plus Induction Chemotherapy in Previously Untreated Patients With High-Risk, Acute Myeloid Leukaemia: A Single-Arm, Phase 2 TrialAndrew M. Brunner, Traci M. Blonquist, Daniel J. DeAngelo, Malgorzata McMasters, Geoffrey Fell
The Lancet. Haematology. 2020-02-01
Abstracts/Posters
- Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical, Clinical, and Correlative StudiesMarlise Luskin, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Phase I Trial of Escalating Doses of the Bcl-2 Inhibitor Venetoclax in Combination with Daunorubicin/Cytarabine Induction and High Dose Cytarabine Consolidation in Pre...Marlise Luskin, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Characteristics and Outcome of Patients with Core Binding Factor Acute Myeloid Leukemia and FLT3-ITD: Results from an International CollaborationMarlise Luskin, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Join now to see all
Lectures
- A Phase I Study of Asciminib (ABL001) in Combination with Dasatinib and Prednisone for Untreated BCR-ABL1-Positive ALL in Older Adults61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Sleep Disturbance Among Patients with Myelodysplastic Syndromes and Acute Leukemia61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Clinical Characteristics of GNB1 and GNAS Mutations in an Unselected Cohort of 6,343 Patients with Hematologic Abnormalities2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Join now to see all
Press Mentions
- Boston College Grad Celebrates ‘Double Graduation’ from School and Cancer TreatmentJune 6th, 2021
- Ruxolitinib in Thrombocythemia and Polycythemia VeraNovember 25th, 2020
- CML & Pregnancy: Patient & Partner ConsiderationsJune 5th, 2018
- Join now to see all
Professional Memberships
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: